Counterpoint: alternative trial designs for antifungal drugs--time to talk.
Powers
J H
JH
Division of Special Pathogen and Immunologic Drug Products, Center for Drug Evaluation and Research, United States Food and Drug Administration, Rockville, MD, USA. POWERSJOH@cder.fda.gov
D000935:Antifungal Agents / Q000627:therapeutic use*; D018849:Controlled Clinical Trials as Topic / Q000379:methods*; D006801:Humans; D009181:Mycoses / Q000175:diagnosis / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic / Q000379:methods*; D012107:Research Design; D016896:Treatment Outcome
D000935:Antifungal Agents